Healthcare / Medical Care FacilitiesHKSE
$1.90
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $193.1M · quality 76.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
54/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$635M
P/E
5.4x
↓EV/EBITDA
2.4x
↓ROE
6.6%
↑Gross Margin
18.2%
↓Debt/Equity
0.22
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.1%
FCF CAGR
+30.2%
FCF margin
11.6%
FCF / Net income
2.35x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.02B · net income $99.6M · FCF $234.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.02B | $2.02B | $2.06B | $2.04B | $1.85B |
| Net Income | $99.6M | $99.6M | $15.3M | $121.1M | $59.7M |
| EBITDA | $297.7M | $297.7M | $224.9M | $305.9M | $233.8M |
| EPS | 0.30 | 0.30 | 0.05 | 0.36 | 0.18 |
| Gross Margin | 18.2% | 18.2% | 15.7% | 17.8% | 14.2% |
| Operating Margin | 5.9% | 5.9% | 2.2% | 5.9% | 2.1% |
| Net Margin | 4.9% | 4.9% | 0.7% | 5.9% | 3.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.22 | 0.22 | 0.22 | 0.30 | 0.29 |
| Current Ratio | 1.35 | 1.35 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $234.5M | $234.5M | $193.1M | $73.3M | $106.2M |
| Returns | |||||
| ROE | 6.6% | 6.6% | 1.1% | 8.5% | 4.0% |
| Valuation | |||||
| P/E | 5.43 | 5.43 | 52.39 | 5.72 | 12.57 |
| EV/EBITDA | 2.45 | 2.45 | 3.93 | 2.66 | 3.93 |
| P/B | 0.42 | 0.42 | 0.56 | 0.49 | 0.50 |
| Growth & Yield | |||||
| Revenue Growth | -1.5% | -1.5% | 0.7% | 10.6% | — |
| EPS Growth | 547.8% | 547.8% | -87.3% | 102.2% | — |
| Dividend Yield | 9.5% | 9.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-17.3%
EPS terminal req.
$0.17
Spread vs growth
565.1%
5Y implied EPS CAGR
-7.3%
EPS terminal req.
$0.20
Spread vs growth
555.1%
10Y implied EPS CAGR
1.0%
EPS terminal req.
$0.33
Spread vs growth
546.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+12.2%
Start / end P/E
40.2x → 6.4x
EPS bridge
0.05 → 0.30
Residual
-461.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.